Ligand (LGND +1.5%) continues to move up following the FDA's approval of Onyx's (ONXX) Kyprolis....

|About: Ligand Pharmaceuticals Inco... (LGND)|By:, SA News Editor

Ligand (LGND +1.5%) continues to move up following the FDA's approval of Onyx's (ONXX) Kyprolis. The drug is to be used for the treatment of relapsed and refractory multiple myelomas, and was developed using LGND's Capitsol formulation system.